Carla Verissimo

Carla Verissimo

Company: HUB Organoids

Job title: Head of Oncology II


HUB Organoids as a New Diagnostic Platform to Improve Cancer Patient Treatment 2:20 pm

How to generate unique clinically relevant patient-derived models using HUB Organoid Technology HUB Organoids capture tumour heterogeneity and preserve tumour genetic make-up and pathology Published clinical data have shown that HUB Organoids mimic patient response The use of an organoid-based platform for drug screening, patient stratification, and personalised medicine approachesRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.